Evidence map›Paper›PMID 38668547›Full record

ArticleTropical medicine and infectious disease2024

Impact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis.

Lucie Ailhaud, Robinson Gravier-Dumonceau, Florent Arregle, Sandrine Hubert, Jean-Paul Casalta, Alberto Riberi, Laetitia Tessonnier, Roch Giorgi, Gilbert Habib, Frédérique Gouriet

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lucie AilhaudMicrobes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France.ORCID 0009-0007-1857-5784
Robinson Gravier-DumonceauBioSTIC, Department of Biostatistics and Information and Communication Technologies, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Florent ArregleDepartment of Cardiology, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Sandrine HubertDepartment of Cardiology, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Jean-Paul CasaltaMicrobes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France.
Alberto RiberiDepartment of Cardiac Surgery, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Laetitia TessonnierDepartment of Nuclear Imagery, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Roch GiorgiBioSTIC, Department of Biostatistics and Information and Communication Technologies, Assistance Publique-Hopitaux de Marseille (AP-HM), La Timone Hospital, 13005 Marseille, France.
Gilbert HabibMicrobes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France.
Frédérique GourietMicrobes Evolution Phylogeny and Infections (MEPHI), Assistance Publique-Hopitaux de Marseille (AP-HM), Aix Marseille University, 13005 Marseille, France.
Assistance Publique Hôpitaux de Marseille · FRAix-Marseille Université · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically.

objectivesThe objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE.

methodsWe conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups.

resultsA total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (

conclusionsThe SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.

Indexed as

COVID-19infective endocarditisintravenous drug usemanagementmortalitypandemicprognosisSARS-CoV-2

Identifiers

PMID38668547
PMCPMC11054848
OpenAlexW4394891813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.